LivaNova Reports Second Quarter 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
Livanova (LIVN) PT Raised to $91 at Needham & Company
July 31, 2019 1:33 PM EDTNeedham & Company analyst Mike Matson raised the price target on Livanova (NASDAQ: LIVN) to $91.00 (from $87.00) while maintaining a Buy rating.
The analyst commented, "LIVN's 2Q19 revenue and EPS beat consensus and management reiterated its 2019 guidance. Organic revenue growth slowed to (1%) in 2Q19... More
LivaNova plc (LIVN) Tops Q2 EPS by 5c
July 31, 2019 6:16 AM EDTLivaNova plc (NASDAQ: LIVN) reported Q2 EPS of $0.70, $0.05 better than the analyst estimate of $0.65. Revenue for the quarter came in at $272.2 million versus the consensus estimate of $275.08 million.
"Sales results for second quarter 2019 were strong in Cardiovascular, driven by double-digit growth in Advanced... More
